SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JamesK who wrote (604)12/6/2021 12:18:26 PM
From: Area51  Read Replies (2) of 684
 
<<PASG Passage Bio getting down close to cash value.>>

Is it there yet?

Another one I think is interesting is BCEL, Per Q3 report they have (Current Assets - Total Liabilities)/37 million shares of 3.18 per share. Currently at 3.31 but closed under 3 on Friday. 27 million per quarter of cash burn, Analyst price target of 24 would be a nice return: marketbeat.com

Seems like if someone did a screen now for biotechs trading under cash value they might get several (dozens?) hits. Please post if you find anything that looks good.

Thanks, A51
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext